Cargando…
Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study
BACKGROUND: Electronic healthcare databases are of increasing importance in health research and mortality is one of the most relevant outcomes. However, data in these databases need to be validated, since they are often generated for reimbursement purposes. The aims of this study were to compare mor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474340/ https://www.ncbi.nlm.nih.gov/pubmed/26087768 http://dx.doi.org/10.1186/s12889-015-1943-7 |
_version_ | 1782377257090678784 |
---|---|
author | Ohlmeier, Christoph Langner, Ingo Hillebrand, Kathrin Schmedt, Niklas Mikolajczyk, Rafael Riedel, Oliver Garbe, Edeltraut |
author_facet | Ohlmeier, Christoph Langner, Ingo Hillebrand, Kathrin Schmedt, Niklas Mikolajczyk, Rafael Riedel, Oliver Garbe, Edeltraut |
author_sort | Ohlmeier, Christoph |
collection | PubMed |
description | BACKGROUND: Electronic healthcare databases are of increasing importance in health research and mortality is one of the most relevant outcomes. However, data in these databases need to be validated, since they are often generated for reimbursement purposes. The aims of this study were to compare mortality figures from the German Pharmacoepidemiological Research Database (GePaRD) on an aggregated level with external data from the Federal Statistical Office of Germany (FSOG) and to assess consistency of records of death from core data and hospital data within GePaRD. METHODS: The study population comprised insurants of four statutory health insurances providing data for GePaRD with either continuous insurance coverage from January 1(st) to December 31(st) 2006 or until death. The sex-specific mortality rate, stratified and standardized by age, and the percentage of hospital deaths among all deaths was compared with data from the FSOG. Furthermore, the agreement between the dates of death according to hospital data and core data was assessed within GePaRD. RESULTS: The study population comprised 12,033,622 insurants. Compared to FSOG data, the age-standardised mortality rate in GePaRD was 21 % and 29 % lower in women and men, respectively. Regional analyses also indicated lower mortality rates in all federal states except for Bremen, where the age-standardised mortality rate was similar to FSOG data for both sexes. The percentage of hospital deaths among all deaths corresponded well with external data. The proportion of inpatient deaths also recorded in the health insurance core data was 98.5 %. Furthermore, 94 % of dates of death documented in hospital agreed with the dates of death according to the health insurance core data. CONCLUSIONS: The lower mortality rates in almost all federal states might result from the higher socioeconomic status of the GePaRD study population compared to the overall population in Germany. In the federal state of Bremen, where socioeconomic representativeness is higher due to additional inclusion of two local health insurances, the mortality rates were in good accordance with external data. Agreement of the percentage of hospital deaths among all deaths between GePaRD and national statistics suggested completeness of outpatient mortality information. |
format | Online Article Text |
id | pubmed-4474340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44743402015-06-20 Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study Ohlmeier, Christoph Langner, Ingo Hillebrand, Kathrin Schmedt, Niklas Mikolajczyk, Rafael Riedel, Oliver Garbe, Edeltraut BMC Public Health Research Article BACKGROUND: Electronic healthcare databases are of increasing importance in health research and mortality is one of the most relevant outcomes. However, data in these databases need to be validated, since they are often generated for reimbursement purposes. The aims of this study were to compare mortality figures from the German Pharmacoepidemiological Research Database (GePaRD) on an aggregated level with external data from the Federal Statistical Office of Germany (FSOG) and to assess consistency of records of death from core data and hospital data within GePaRD. METHODS: The study population comprised insurants of four statutory health insurances providing data for GePaRD with either continuous insurance coverage from January 1(st) to December 31(st) 2006 or until death. The sex-specific mortality rate, stratified and standardized by age, and the percentage of hospital deaths among all deaths was compared with data from the FSOG. Furthermore, the agreement between the dates of death according to hospital data and core data was assessed within GePaRD. RESULTS: The study population comprised 12,033,622 insurants. Compared to FSOG data, the age-standardised mortality rate in GePaRD was 21 % and 29 % lower in women and men, respectively. Regional analyses also indicated lower mortality rates in all federal states except for Bremen, where the age-standardised mortality rate was similar to FSOG data for both sexes. The percentage of hospital deaths among all deaths corresponded well with external data. The proportion of inpatient deaths also recorded in the health insurance core data was 98.5 %. Furthermore, 94 % of dates of death documented in hospital agreed with the dates of death according to the health insurance core data. CONCLUSIONS: The lower mortality rates in almost all federal states might result from the higher socioeconomic status of the GePaRD study population compared to the overall population in Germany. In the federal state of Bremen, where socioeconomic representativeness is higher due to additional inclusion of two local health insurances, the mortality rates were in good accordance with external data. Agreement of the percentage of hospital deaths among all deaths between GePaRD and national statistics suggested completeness of outpatient mortality information. BioMed Central 2015-06-20 /pmc/articles/PMC4474340/ /pubmed/26087768 http://dx.doi.org/10.1186/s12889-015-1943-7 Text en © Ohlmeier et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ohlmeier, Christoph Langner, Ingo Hillebrand, Kathrin Schmedt, Niklas Mikolajczyk, Rafael Riedel, Oliver Garbe, Edeltraut Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title | Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title_full | Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title_fullStr | Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title_full_unstemmed | Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title_short | Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study |
title_sort | mortality in the german pharmacoepidemiological research database (gepard) compared to national data in germany: results from a validation study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474340/ https://www.ncbi.nlm.nih.gov/pubmed/26087768 http://dx.doi.org/10.1186/s12889-015-1943-7 |
work_keys_str_mv | AT ohlmeierchristoph mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT langneringo mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT hillebrandkathrin mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT schmedtniklas mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT mikolajczykrafael mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT riedeloliver mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy AT garbeedeltraut mortalityinthegermanpharmacoepidemiologicalresearchdatabasegepardcomparedtonationaldataingermanyresultsfromavalidationstudy |